BCL2 and lymphoma: One of the limitations of earlier studies is that the assessed patient cohorts were a mixed group that included MYC single hit lymphoma, all types of DHL and triple hit lymphomas, and patients did not receive immunochemotherapy in the study by Aukema et al. In this study, there were 40 cases of MYC/BCL2 DHL in which the partner of MYC is known.